Nephros (NEPH) Return on Capital Employed (2011 - 2026)

Nephros' Return on Capital Employed history runs 16 years deep, the most recent figure standing at 6.05% for Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 169.0% year-over-year to 6.05% in Q1 2026; TTM through Mar 2026 was 6.05%, a 169.0% decrease from a year earlier, with the FY2025 full-year figure at 11.87%, up 1181.0% from the prior year.
• Return on Capital Employed eased to 6.05% in Q1 2026 per NEPH's latest filing, from 10.73% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 14.06% in Q3 2025 and bottomed at 44.44% in Q4 2022.
• The 5-year median for Return on Capital Employed is 15.31% (2024), against an average of 13.23%.
• Across the five-year window, Return on Capital Employed slumped 2060 bps in 2022 and jumped 2777 bps in 2025, its largest moves.
• Year by year, Return on Capital Employed stood at 44.44% in 2022, then jumped by 61 bps to 17.17% in 2023, then surged by 100 bps to 0.06% in 2024, then surged by 16422 bps to 10.73% in 2025, then slumped by 44 bps to 6.05% in 2026.
• Per Business Quant, the three latest NEPH Return on Capital Employed figures stand at 6.05% (Q1 2026), 10.73% (Q4 2025), and 14.06% (Q3 2025).